Activity and safety of cabozantinib (cabo) in brain metastases (BM) from metastatic renal cell carcinoma (mRCC): An international multicenter study.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Laure Hirsch, Nieves Martinez Chanza, Subrina Farah, Ronan Flippot, Nityam Rathi, Katharine Collier, Guillermo de Velasco, Emmanuel Seront, Benoit Beuselinck, Wenxin Xu, Isaac Alexander Bowman, Elaine Tat Lam, Hannah Elizabeth Dzimitrowicz, Yousef Zakharia, Rana R. McKay, Mehmet Asim Bilen, Laurence Albiges, Wanling Xie, Lauren C Harshman, Toni K. Choueiri
Institutions: Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Université Paris Descartes, Université Libre de Bruxelles, Institut Jules Bordet, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Institut Gustave Roussy, Fondation Gustave Roussy, University of Utah, Huntsman Cancer Institute, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Hospital Universitario 12 De Octubre, Universitair Ziekenhuis Leuven, Beth Israel Deaconess Medical Center, The University of Texas Southwestern Medical Center, University of Colorado Cancer Center, Duke Medical Center, Duke Cancer Institute, University of Iowa, University of Iowa Holden Comprehensive Cancer Center, Moores Cancer Center, Winship Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3133584699